Literature DB >> 16177376

Expression of matrix metalloproteinases subsequent to urogenital Chlamydia muridarum infection of mice.

K H Ramsey1, I M Sigar, J H Schripsema, N Shaba, K P Cohoon.   

Abstract

The central hypothesis of this study was that matrix metalloproteinases (MMPs) would be enhanced following murine chlamydial infection and that their expression would vary in mouse strains that differ in their susceptibility to chronic chlamydia-induced disease. To address this hypothesis, female C3H/HeN and C57BL/6 mice were infected intravaginally with Chlamydia muridarum. Uterine and oviduct tissues were assessed for transcription of MMP genes and their tissue inhibitors. An increased activity of MMP genes relative to preinfection tissues was observed in the C3H/HeN mice when compared to C57BL/6 mice. Using gelatin zymography, we detected constitutive MMP-2 activity in both strains of mice but an increase in MMP-9. Casein zymography indicated the presence of two elastase-like activities consistent with MMP-12 and possibly MMP-7. Western blotting and antigen capture enzyme-linked immunoassay also confirmed an increase in MMP-9 but constitutive MMP-2 expression subsequent to the infection in both strains of mice. In C57BL/6 mice, MMP-9 was present in monomer and dimer form throughout the 56-day monitoring period. C3H/HeN mice produced dimeric MMP-9, but increases in the monomer form were also observed through day 14. Post-translational modification of MMP-9 between the two strains also differed. Immunohistochemistry revealed neutrophils as a prominent source for MMP-9 in both strains of mice. We conclude that differences in the relative expression and activity of MMPs, particularly MMP-9, occur in mice differing in their susceptibility to the development of chronic chlamydial disease. These differences may account for disparate outcomes with regard to chronic sequelae of the disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177376      PMCID: PMC1230927          DOI: 10.1128/IAI.73.10.6962-6973.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes.

Authors:  Marta Toth; Irina Chvyrkova; M Margarida Bernardo; Sonia Hernandez-Barrantes; Rafael Fridman
Journal:  Biochem Biophys Res Commun       Date:  2003-08-22       Impact factor: 3.575

Review 2.  Collagenolytic metalloenzymes of the human neutrophil. Characteristics, regulation and potential function in vivo.

Authors:  S J Weiss; G J Peppin
Journal:  Biochem Pharmacol       Date:  1986-10-01       Impact factor: 5.858

3.  Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils.

Authors:  G J Peppin; S J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  A theoretical model of type I collagen proteolysis by matrix metalloproteinase (MMP) 2 and membrane type 1 MMP in the presence of tissue inhibitor of metalloproteinase 2.

Authors:  Emmanouil D Karagiannis; Aleksander S Popel
Journal:  J Biol Chem       Date:  2004-07-12       Impact factor: 5.157

5.  Cellular immunity to the mouse pneumonitis agent.

Authors:  D M Williams; J Schachter; J J Coalson; B Grubbs
Journal:  J Infect Dis       Date:  1984-04       Impact factor: 5.226

6.  Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection.

Authors:  Toni Darville; Joshua M O'Neill; Charles W Andrews; Uma M Nagarajan; Lynn Stahl; David M Ojcius
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

Review 7.  Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes.

Authors:  Francis J Descamps; Philippe E Van den Steen; Inge Nelissen; Jo Van Damme; Ghislain Opdenakker
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

8.  Chlamydia trachomatis-induced salpingitis in mice.

Authors:  C E Swenson; E Donegan; J Schachter
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

9.  Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade.

Authors:  Rita Dreier; Susanne Grässel; Susanne Fuchs; Jens Schaumburger; Peter Bruckner
Journal:  Exp Cell Res       Date:  2004-07-15       Impact factor: 3.905

10.  Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities.

Authors:  Philippe E Van Den Steen; Anja Wuyts; Steven J Husson; Paul Proost; Jo Van Damme; Ghislain Opdenakker
Journal:  Eur J Biochem       Date:  2003-09
View more
  30 in total

1.  Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.

Authors:  Ashlesh K Murthy; James P Chambers; Patricia A Meier; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

Review 2.  Pathogenesis of genital tract disease due to Chlamydia trachomatis.

Authors:  Toni Darville; Thomas J Hiltke
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

3.  Discovery of Blood Transcriptional Endotypes in Women with Pelvic Inflammatory Disease.

Authors:  Xiaojing Zheng; Catherine M O'Connell; Wujuan Zhong; Uma M Nagarajan; Manoj Tripathy; De'Ashia Lee; Ali N Russell; Harold Wiesenfeld; Sharon Hillier; Toni Darville
Journal:  J Immunol       Date:  2018-03-12       Impact factor: 5.422

4.  Enhanced neutrophil longevity and recruitment contribute to the severity of oviduct pathology during Chlamydia muridarum infection.

Authors:  Lauren C Frazer; Catherine M O'Connell; Charles W Andrews; Matthew A Zurenski; Toni Darville
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

5.  Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection.

Authors:  Muhammad T Imtiaz; Justin H Schripsema; Ira M Sigar; John N Kasimos; Kyle H Ramsey
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

6.  Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8+ T Cells and TNF Receptor Superfamily Member 1a on Non-CD8+ T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection.

Authors:  Srikanth Manam; Joshua D Thomas; Weidang Li; Allison Maladore; Justin H Schripsema; Kyle H Ramsey; Ashlesh K Murthy
Journal:  J Infect Dis       Date:  2014-12-30       Impact factor: 5.226

7.  Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not required for macrophage influx or normal resolution of infection.

Authors:  Amy M Scurlock; Lauren C Frazer; Charles W Andrews; Catherine M O'Connell; Isaac P Foote; Sarabeth L Bailey; Kumar Chandra-Kuntal; Jay K Kolls; Toni Darville
Journal:  Infect Immun       Date:  2010-12-13       Impact factor: 3.441

8.  A role for matrix metalloproteinase-9 in pathogenesis of urogenital Chlamydia muridarum infection in mice.

Authors:  Muhammad T Imtiaz; John T Distelhorst; Justin H Schripsema; Ira M Sigar; John N Kasimos; Shanon R Lacy; Kyle H Ramsey
Journal:  Microbes Infect       Date:  2007-09-08       Impact factor: 2.700

9.  A new methodology for monitoring the activity of cdMMP-12 anchored and freeze-dried on Au (111).

Authors:  Giuseppe Grasso; Marco Fragai; Enrico Rizzarelli; Giuseppe Spoto; Kwon Joo Yeo
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-23       Impact factor: 3.109

10.  Innate immunity in ocular Chlamydia trachomatis infection: contribution of IL8 and CSF2 gene variants to risk of trachomatous scarring in Gambians.

Authors:  Angels Natividad; Jeremy Hull; Gaia Luoni; Martin Holland; Kirk Rockett; Hassan Joof; Matthew Burton; David Mabey; Dominic Kwiatkowski; Robin Bailey
Journal:  BMC Med Genet       Date:  2009-12-16       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.